Anti stress agent:

Oxidative stress refers to the situations in which the body’s antioxidant and other defensive abilities to combat free radicals (a.k.a highly reactive species of oxygen and nitrogen) are overwhelmed and one’s normal healthy balance is either lost or severely compromised. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.  Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. 

http://www.oxis.com  Oxis on Twitter

Oxis on facebook

products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. 

This blog post deals about the oxidative stress discovered by OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious.

Oxidative stress refers to the situations in which the body’s antioxidant and other defensive abilities to combat free radicals (a.k.a highly reactive species of oxygen and nitrogen) are overwhelmed and one’s normal healthy balance is either lost or severely compromised. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.  Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. 

http://www.oxis.com  Oxis on Twitter

Oxis on facebook

products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. 

This blog post deals about the oxidative stress discovered by OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious.